SCHEMBL12691162

SCHEMBL12691162

CCC(C)C(=O)Oc1ccc(/N=N/c2ccc(C#N)cc2)cc1

nearest known ligand 0.45

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ MGLL Q99685 2/20 0.45
▸ PPARD Q03181 2/20 0.45
▸ PPARA Q07869 2/20 0.45
▸ MMP2 P08253 1/20 0.43
▸ MMP3 P08254 1/20 0.43
▸ ELANE P08246 1/20 0.41
▸ MAPT P10636 3/20 0.40
▸ ALDH1A1 P00352 2/20 0.40
▸ RAB9A P51151 1/20 0.39
▸ HRH3 Q9Y5N1 2/20 0.39
▸ CYP11B1 P15538 1/20 0.38
▸ CYP11B2 P19099 1/20 0.38
▸ LMNA P02545 1/20 0.38
▸ TP53 P04637 1/20 0.38
▸ CYP1A2 P05177 1/20 0.38
▸ CYP2D6 P10635 1/20 0.38
▸ HIF1A Q16665 1/20 0.38
▸ CYP1B1 Q16678 1/20 0.38
▸ F2 P00734 1/20 0.37
▸ PRSS1 P07477 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13750796 1.00 MGLL (0.45) MGLLPPARDPPARAMMP2MMP3
SCHEMBL10033505 0.92 MGLL (0.51) MGLLMMP2MMP3ELANEMAPT
SCHEMBL17208955 0.88 MGLL (0.46) MGLLPPARDPPARAMMP2MMP3
SCHEMBL11147711 0.87 MMP2 (0.56) MGLLMMP2MMP3MAPTALDH1A1
SCHEMBL14791143 0.86 PPARA (0.53) PPARDPPARAMMP2MMP3MAPT
SCHEMBL17131748 0.85 PPARA (0.49) MGLLPPARDPPARAMMP2MMP3
SCHEMBL17131747 0.83 MAPT (0.46) PPARDPPARAELANEMAPTALDH1A1
SCHEMBL17131758 0.83 ELANE (0.45) PPARDPPARAELANEMAPTALDH1A1
SCHEMBL9912636 0.83 MAPT (0.47) PPARDPPARAELANEMAPTALDH1A1
SCHEMBL14791144 0.83 PPARA (0.50) PPARDPPARAMMP2MMP3MAPT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8575228-B2 Anisotropic liquid surface forming agent and anisotropic liquid surface forming method FUJIFILM CORPORATION (JP) 2013-11-05 — — US disclosed
US-20120245247-A1 ANISOTROPIC LIQUID SURFACE FORMING AGENT AND ANISOTROPIC LIQUID SURFACE FORMING METHOD FUJIFILM CORPORATION (JP) 2012-09-27 — — US disclosed
US-20090286005-A1 Anisotropic liquid surface forming agent and anisotropic liquid surface forming method FUJIFILM CORPORATION (JP) 2009-11-19 — — US disclosed
US-20090086140-A1 PHOTO ALIGNMENT FILM AND RETARDATION FILM, AND THEIR APPLICATIONS, AND COMPOSITIONS AND METHODS FOR PRODUCING THEM FUJIFILM CORPORATION (JP) 2009-04-02 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090086140-A1 PHOTO ALIGNMENT FILM AND RETARDATION FILM, AND THEIR APPLICATIONS, AND COMPOSITIONS AND METHODS FOR PRODUCING THEM CRY1, COL1A1, COL14A1 MGLL 997/4885PPARD 4515/4885PPARA 3680/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback